U
UTHR
United Therapeutics Corp.
493.99
5.48+1.12%After Hours: 493.99 0.00 0.00%17:11 12/12 EST
OPEN/PREV CLOSE491.00/488.51
TODAY RANGE488.75-496.73
VOL638.83K
MARKET CAP21.27B
52 WEEK RANGE266.98-496.73
AVG VOL (3M)615.89K
% TURNOVER1.48%
TURNOVER--
P/E (TTM)18.70
% RANGE1.60%
EPS(TTM)26.41
P/E(FORWARD)17.89
P/B3.216
BVPS153.61
DIVIDEND--
P/S7.70
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP20.82B
SHARES OUTSTANDING43.06M
NEXT EARNINGS02/24-03/02
FREE FLOAT42.14M
LOT SIZE1
EX-DATE09/23/2009
News
Press Releases
Financial Reports
Profile
Simply Wall St·2d ago
United Therapeutics (UTHR): Valuation Check After Insider Sales and Mixed Revenue Versus Analyst Expectations
TipRanks·3d ago
Director Cashes In on United Therapeutics Stock Sale!
Simply Wall St·12/06 13:17
How Investors Are Reacting To United Therapeutics (UTHR) Q3 Growth, 2027 Outlook and Insider Selling
Reuters·12/05 21:54
United Therapeutics CEO Martine Rothblatt Reports Disposal of Common Shares
NASDAQ·12/05 15:52
SPMD, COHR, LITE, UTHR: Large Outflows Detected at ETF
NASDAQ·12/04 16:20
Can Merck's New Products Aid Growth as Keytruda LOE Test Looms?
Simply Wall St·12/04 14:27
United Therapeutics (UTHR): Revisiting Valuation After Q3 2025 Growth, Strong 2027 Guidance and Rising Institutional Interest
Same Industry
Name/Symbol
Change%
Price